General Information of Drug (ID: DM750LD)

Drug Name
Chromomycin a3 Drug Info
Cross-matching ID
PubChem CID
656673
ChEBI ID
CHEMBL34638
CAS Number
CAS 7059-24-7
TTD Drug ID
D03KTD

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Valine, leucine and isoleucine degradation 2.39 0.00e+0 42/48 (87.5%) ALDH2;ACADM;BCAT1;...
Lysosome 2.12 0.00e+0 115/128 (89.84%) PPT1;SCARB2;CTSV;...
Oxidative phosphorylation 2.09 3.39e-3 93/133 (69.92%) ATP6V0B;ATP6AP1;NDUFB4;...
Primary immunodeficiency 1.88 1.27e-2 33/38 (86.84%) RFX5;IL2RG;BLNK;...
Protein digestion and absorption 1.87 1.02e-2 78/103 (75.73%) COL3A1;COL5A2;COL1A2;...
N-Glycan biosynthesis 1.86 8.47e-3 38/50 (76%) DAD1;STT3A;MAN1C1;...
Phagosome 1.85 1.02e-2 118/152 (77.63%) TLR4;THBS2;TFRC;...
Rheumatoid arthritis 1.83 1.02e-2 78/93 (83.87%) TLR4;CXCL8;ATP6V0B;...
beta-Alanine metabolism 1.79 1.92e-2 25/30 (83.33%) ALDH2;ALDH3B1;ALDH3A2;...
ECM-receptor interaction 1.78 2.13e-2 80/88 (90.91%) COL1A2;THBS2;COL4A5;...
Malaria 1.77 2.03e-2 44/50 (88%) TLR4;THBS2;HGF;...
Arginine and proline metabolism 1.76 2.20e-2 39/50 (78%) ALDH2;PYCR1;CKB;...
Alanine, aspartate and glutamate metabolism 1.74 2.50e-2 27/37 (72.97%) ALDH5A1;ASNS;GLS;...
Hematopoietic cell lineage 1.73 2.32e-2 90/99 (90.91%) TFRC;HLA-DQA1;ITGA4;...
Butanoate metabolism 1.72 2.51e-2 23/28 (82.14%) ALDH5A1;OXCT1;BDH2;...
Protein export 1.72 2.48e-2 17/23 (73.91%) SRP9;SPCS1;SRP54;...
Various types of N-glycan biosynthesis 1.72 2.39e-2 26/39 (66.67%) DAD1;STT3A;MAN1C1;...
Intestinal immune network for IgA production 1.71 2.48e-2 38/48 (79.17%) CXCL12;HLA-DQA1;ITGA4;...
Biosynthesis of unsaturated fatty acids 1.70 2.35e-2 21/27 (77.78%) SCP2;ACAA1;HSD17B4;...
Synthesis and degradation of ketone bodies 1.67 3.30e-2 9/10 (90%) OXCT1;BDH2;HMGCS2;...
Other types of O-glycan biosynthesis 1.65 3.82e-2 29/47 (61.7%) GALNT7;GALNT12;GALNT2;...
Vibrio cholerae infection 1.62 4.53e-2 44/50 (88%) GNAS;ATP6V0B;ATP6AP1;...
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis 1.62 4.42e-2 20/26 (76.92%) PIGK;PIGT;PIGG;...
Viral myocarditis 1.61 4.74e-2 53/60 (88.33%) CXADR;HLA-DQA1;HLA-C;...
Glycosaminoglycan degradation 1.61 4.55e-2 19/19 (100%) IDS;GUSB;GLB1;...
Complement and coagulation cascades 1.60 4.65e-2 76/85 (89.41%) PLAUR;SERPING1;CFH;...
Cell cycle -1.75 3.44e-2 110/124 (88.71%) ORC5;CCNA1;ORC1;...
MicroRNAs in cancer -1.77 3.09e-2 146/310 (47.1%) CCNE2;MAPK7;THBS1;...
Ribosome -1.78 2.62e-2 113/158 (71.52%) RPL19;RPL14;RPS19;...
RNA transport -1.78 3.15e-2 128/186 (68.82%) THOC5;EIF3E;POP1;...
FoxO signaling pathway -1.79 3.20e-2 118/131 (90.08%) PLK4;BCL6;CSNK1E;...
Chronic myeloid leukemia -1.83 2.29e-2 72/76 (94.74%) E2F3;MDM2;BAD;...
ErbB signaling pathway -1.91 1.48e-2 79/85 (92.94%) RPS6KB1;SOS2;SOS1;...
Ribosome biogenesis in eukaryotes -2.18 0.00e+0 52/108 (48.15%) NHP2;POP4;PWP2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
1HAEo- CVCL_0128 Homo sapiens 10uM 24H
NL20 CVCL_0461 Homo sapiens 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Normal (Fibroblast)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HFL1 CVCL_4295 Homo sapiens 10uM 24H
IMR-90 CVCL_0347 Homo sapiens 10uM 24H
WI-38 CVCL_0579 Homo sapiens 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H